| Ytd | -2.44% | |
| 1y | 8.50% |
| Open | 5.73 | Prev Close | 5.71 | Low | 5.72 | High | 6.00 | Mkt Cap | 566.69M |
| Vol | 1.63M | Avg Vol | 1.63M | EPS | -4.31 | P/E | N/A | Forward P/E | 71.53 |
| Beta | 1.89 | Short Ratio | 4.83 | Inst. Own | 103.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 4.50 | 200-d Avg | 5.80 | 1yr Est | 19.41 |
Myriad (MYGN) was a big mover last session on higher-than-average trading volume. The latest trend i
Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicin